Document is current

Article History

Received: 2 June 2020

Revised: 10 August 2020

Accepted: 12 August 2020

First Online: 5 September 2020

Compliance with ethical standards

:

: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. Katharina Feil reports no disclosures. Jan Rémi reports no disclosures. Clemens Küpper reports no disclosures. Moriz Herzberg reports no disclosures. Franziska Dorn reports no disclosures. Wolfgang G. Kunz reports grant funding from LMU Munich and the German Research Foundation. Paul Reidler reports grant funding from LMU Munich. Johannes Levin reports no disclosures. Katrin Hüttemann reports no disclosures. Steffen Tiedt reports no disclosures. Wanja Heidger reports no disclosures. Katharina Müller reports no disclosures. Dennis C. Thunstedt reports no disclosures. Rainer Dabitz reports no disclosures. Robert Müller reports no disclosures. Thomas Pfefferkorn reports no disclosures. Gerhard F. Hamann reports no disclosures. Thomas Liebig consults for Stryker Neurovascular GmbH and has received speaker honoraria from Pfizer, Covidien, Phenox, and Microvention outside this study. Marianne Dieterich reports no disclosures. Lars Kellert has received funding for travel or speaker honoraria from Bayer Vital, Boehringer Ingelheim, Bristol-Meyer-Squibb, Daiichi Sankyo, and Pfizer outside of this study.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.